American Beacon Stephens Sm Cp Gr Inv holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
American Beacon Stephens Small Cap Growth Fund Investor Class STSGX
- NAV / 1-Day Return $13.81 / +1.25 %
- Fund Size $535.1M
- Adjusted Expense Ratio 1.270%
- Net Expense Ratio 1.280%
- Fee Level: Distribution Above Average
- Share Class Type No Load
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $2,500
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 35%
Morningstar’s Analysis STSGX
Will STSGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Halozyme Therapeutics Inc | 2.03 | 11M | Healthcare |
Ligand Pharmaceuticals Inc | 1.99 | 11M | Healthcare |
Repligen Corp | 1.93 | 10M | Healthcare |
FirstCash Holdings Inc | 1.91 | 10M | Financial Services |
Xometry Inc Ordinary Shares - Class A | 1.88 | 10M | Industrials |
Travere Therapeutics Inc Ordinary Shares | 1.84 | 10M | Healthcare |
EZCORP Inc Registered Shs -A- Non Vtg | 1.77 | 9M | Financial Services |
Manhattan Associates Inc | 1.76 | 9M | Technology |
Twist Bioscience Corp | 1.73 | 9M | Healthcare |
U.S. Government Money Market S | 1.71 | 9M | Cash and Equivalents |